Union Health Minister reviews availability of COVID essential drugs, buffer stocks Medical Dialogues Team2 Sept 2021 12:44 PM ISTThe strategic buffer stock has been created for 8 drugs, all of these are available in the country.
DCGI nod to phase 2, 3 trials of Biological E Corbevax in children Medical Dialogues Team2 Sept 2021 12:31 PM ISTNew Delhi: The Drugs Controller General of India (DCGI) on Wednesday granted permission to Hyderabad-based Biological E Limited to conduct phase 2/3...
Sun Pharma Advanced Research Company to raise up to Rs 1800 crore Medical Dialogues Team2 Sept 2021 9:00 AM ISTNew Delhi: Sun Pharma Advanced Research Company (SPARC) on Wednesday said it will seek shareholders' approval to raise up to Rs 1,800 crore through...
IPC flags adverse reaction linked to Hepatitis C drug Sofosbuvir Medical Dialogues Team1 Sept 2021 2:13 PM ISTNew Delhi: The Indian Pharmacopoeia Commission (IPC) has recently issued a drug safety alert for the month of August, revealing that the antiviral...
NPPA panel fixes retail price of Vildagliptin, Metformin FDCs marketed by Aristo Pharma Medical Dialogues Team31 Aug 2021 5:55 PM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of the popular antidiabetic Fixed-Dose Combination (FDC)...
NPPA panel to examine price of antibacterial FDC Cefixime, Lactic Acid Bacillus Medical Dialogues Team30 Aug 2021 4:10 PM ISTNew Delhi: Holding that unreasonably higher price due to the addition of Lactic acid bacillus to the scheduled formulation of Cefixime 200 mg tablet...
Conduct phase 3 trail of Esomeprazole Gastro-resistant Tablets: CDSCO panel tells Sun Pharma Medical Dialogues Team30 Aug 2021 3:36 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Organization (CDSCO) has recommended Sun Pharma to conduct a...
Regularization of 31 FDCs declared rational: Drugmakers told to submit application within 6 months Medical Dialogues Team29 Aug 2021 11:15 AM ISTNew Delhi: In order to regularize Fixed Dose Combinations (FDCs) declared rational by the DTAB in respect of 294 FDCs, the Central Drugs Standard...
CDSCO decides on fate of 3 antibiotic FDCs including Cefixime, Cloxacilli Medical Dialogues Team28 Aug 2021 4:00 PM ISTNew Delhi: The Central Drugs Standard Control Organization (CDSCO) has asked all State and Union Territory (UT) drugs controllers to direct all the...
NPPA fixes retail price of 19 formulations including Metformin, Dapagliflozin, Details Medical Dialogues Team27 Aug 2021 1:45 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India,...
NPPA panel rejects Cipla application for special pricing of Ciphaler Inhaler Device Medical Dialogues Team26 Aug 2021 5:27 PM ISTNew Delhi: Rejecting pharmaceutical major Cipla's application, the National Pharmaceutical Pricing Authority (NPPA) Committee has denied to allow a...
Natco Pharma loses patent litigation case over anti-cancer drug Ibrutinib in US Medical Dialogues Team25 Aug 2021 6:12 PM ISTNew Delhi: In a major setback, Natco Pharma has lost a legal battle with Pharmacyclics, a subsidiary of AbbVie over patent of anti-cancer drug...
